WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-04 10:14 am Sale |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
WELLINGTON MANAGEMENT GROUP LLP | 2,101,227 4.750% |
-1,219,524 (-36.72%) |
Filing |